학술논문
Phase I study of BAY 94‐9027, a PEGylated B‐domain‐deleted recombinant factor VIII with an extended half‐life, in subjects with hemophilia A
Document Type
Article
Author
Source
In Journal of Thrombosis and Haemostasis April 2014 12(4):488-496
Subject
Language
ISSN
1538-7836